MAP1LC3A and lung cancer: To extend our finding we prepared another paclitaxel resistant lung cancer cell line H596-TxR from paclitaxel sensitive NCI- H596 cells in vitro (Fig. S1B) and examined the status of BECN1 and LC3 in this resistant lung cancer cell line (H596-TxR).